Just Imagine What Vascepa Would Do In The Hands Of Big Pharma!































I'm curious as to what value you seem to think exists for big pharma to buy Amarin? There's no patent and there's already generics in the marketplace! Even if the generic label only includes the Trig reduction aspect we all know that CVRR scripts will be filled with generic anyway. I just don't understand why some people still think a buyout is an option? There's been no rumors on wall street about a buyout in a long time. I'm still working and still interviewing.
 






I'm curious as to what value you seem to think exists for big pharma to buy Amarin? There's no patent and there's already generics in the marketplace! Even if the generic label only includes the Trig reduction aspect we all know that CVRR scripts will be filled with generic anyway. I just don't understand why some people still think a buyout is an option? There's been no rumors on wall street about a buyout in a long time. I'm still working and still interviewing.

Lipitor was 100B.
 






nonymous said:
I'm curious as to what value you seem to think exists for big pharma to buy Amarin? There's no patent and there's already generics in the marketplace! Even if the generic label only includes the Trig reduction aspect we all know that CVRR scripts will be filled with generic anyway. I just don't understand why some people still think a buyout is an option? There's been no rumors on wall street about a buyout in a long time. I'm still working and still interviewing.


Lipitor was 100B.


What does Lipitor have to do with it? Did it grow to 100b as a brand AFTER the patent was lost?
 












I believe it would move to the graveyard/be removed from your bag and you would move on to other branded meds. Most companies have a pipeline.

So people think that Big Pharma wants to buy a sales team, administrators and corporate employees that won't be trained to their standards and probably has a ton of dead weight in it? That makes very little sense to me.